European Society for Immunodeficiencies

Our Pharma team are thrilled to announce our attendance at The ESID 2019 meeting in Brussels from the 18th-21st of September 2019. The theme of the meeting is ‘PID and Malignancy’ and it is being organised by the Local and International Scientific Committee as well as the ESID Board.

The meeting focuses on the fascinating and important intertwinement between primary immunodeficiencies, infections and malignancy. Topics include PIDs with a well-known increased risk of malignancy, (such as DNA repair disorders, CVID, T cell deficiencies) the impact of viral infections on the development of malignancies, the immunology of the tumor microenvironment and much, much more.